EC Communication (part 1): How to address critical medicines shortages
by Giuliana Miglierini As announced on 3 October in the speech given by Commissioner Stella Kyriakides at European…
The UK’s statutory scheme revision for branded medicines
by Giuliana Miglierini The amendment of the statutory schemeregulating the increase in pricing and consequent clawback payments of…
UK will participate to European research programmes
by Giuliana Miglierini The divergent road opened as a consequence of the Brexit, in January 2021, between the…
The proposals of the EU Commission for the revision of the IP legislation
By Giuliana Miglierini In parallel to the new pharmaceutical legislation, on 27 April 2023 the EU Commission issued…
Pioneer plan, UK’s alternative to support research and innovation
By Giuliana Miglierini While the position of the UK with respect to the participation to Horizon Europe (HE)…
New steps towards the activation of the Unified Patent Court
by Giuliana Miglierini The date of 1 April 2023 may mark an important step in the procedures to…